Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 27 Jul 2018 Status changed from not yet recruiting to recruiting.
- 03 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.
- 01 Jun 2018 Planned initiation date changed from 1 May 2018 to 1 Jun 2018.